Senti Biosciences (SNTI) Stock Statistics & Valuation Metrics

Senti Biosciences has a market cap or net worth of $26.78M. The enterprise value is $35.08M.

Senti Biosciences has 31,144,497 shares outstanding. The number of shares has decreased by -2.65% in one year.

Senti Biosciences’s return on equity (ROE) is -10.99 and return on invested capital (ROIC) is -149.67%.

The current PE Ratio of Senti Biosciences is ―. Senti Biosciences’s PEG ratio is 0.05.

In the last 12 months, Senti Biosciences had revenue of 22.00K and earned -61.44M in profits. Earnings per share was -2.73.

In the last 12 months, operating cash flow was -43.44M and capital expenditures -196.00K, giving a free cash flow of -43.64M billion.

Senti Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Senti Biosciences upcoming earnings date is May 12, 2026, After Close (Confirmed).

Senti Biosciences as a current ratio of 1.67, with Debt / Equity ratio of 516.93%

In the past 12 months, Senti Biosciences has paid 0.00 in taxes.

Senti Biosciences EV to EBITDA ratio is -4.10, with an EV/FCF ratio of -5.64.

Senti Biosciences has $16.42M in cash and marketable securities with $28.89M in debt, giving a net cash position of -$12.47M billion.

Gross margin is -14777.27%, with operating margin of -289668.18%, and net profit margin of -279263.64%.

The average price target for Senti Biosciences is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy